AMRSQ — Amyris Income Statement
0.000.00%
- $1.85m
- $947.90m
- $269.85m
Annual income statement for Amyris, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 63.6 | 153 | 173 | 342 | 270 |
Cost of Revenue | |||||
Gross Profit | 26.9 | 76.4 | 86.5 | 188 | 12.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 219 | 319 | 349 | 552 | 839 |
Operating Profit | -156 | -166 | -175 | -210 | -569 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -230 | -242 | -324 | -272 | -539 |
Provision for Income Taxes | |||||
Net Income After Taxes | -230 | -243 | -324 | -264 | -536 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -230 | -243 | -331 | -271 | -529 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -223 | -270 | -382 | -270 | -529 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.3 | -2.38 | -1.71 | -0.825 | -1.65 |